The political downside of 'follow the science'


The White House fended off numerous questions at Wednesday's press briefing about blue state governors easing COVID-19 restrictions, especially mask mandates, earlier than President Biden recommended. The answers were always the same: We're going to follow the Centers for Disease Control and Prevention (CDC), and parents should too, no matter what their Democratic governor says (but also, when those governors loosen rules, it's different and better than when Republican Florida Gov. Ron DeSantis does the same).
That messy briefing was emblematic of a larger problem: The Biden administration is struggling with when to ease pandemic safety guidelines. They've been burned before, prematurely declaring victory as the vaccines rolled out last June only to have to urge people to remask as new variants emerged and a slice of the population remained stubbornly resistant to the shots.
The problem is that when the administration does lift its endorsement of the restrictions, it will be so far behind everyone else — including most Democratic elected officials — that they'll receive little political credit for the return to normalcy. And normalcy was a big, if unspoken, part of Biden's successful campaign pitch.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Yet he's seriously limited his options here. As a candidate, Biden vowed to follow the science, and since taking office, he has defined that to mean the CDC, which Press Secretary Jen Psaki likes to say "moves at the speed of science." But CDC policymakers are also the most risk-averse people on the planet. They would not recommend you eat raw cookie dough or rare hamburgers. For the past two years, most of the country has been following their lead on COVID.
No more. People are beginning to see that there are other factors — economic, cultural, psychological, educational — that have to be considered when weighing virus mitigation measures. Vaccines help. Nearly half of Democrats are ready to move on, along with sizable majorities of everyone else.
While a change in policy may be coming soon, Biden has been boxed in by people who refuse to do this cost-benefit analysis. He also may be appeasing the nontrivial number of his own voters who are extremely COVID-cautious. But that's not going to win him or his party the midterm elections. Expect more messy press conferences to come.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
W. James Antle III is the politics editor of the Washington Examiner, the former editor of The American Conservative, and author of Devouring Freedom: Can Big Government Ever Be Stopped?.
-
Why are military experts so interested in Ukraine's drone attack?
TODAY'S BIG QUESTION The Zelenskyy government's massive surprise assault on Russian airfields was a decisive tactical victory — could it also be the start of a new era in autonomous warfare?
-
Critics push back as the government goes after Job Corps
The Explainer For at-risk teens, the program has been a lifeline
-
5 horror movies to sweat out this summer
The Week Recommends A sequel, a reboot and a follow up from the director of 'Barbarian' highlight the upcoming scary movie slate
-
The Biden cover-up: a 'near-treasonous' conspiracy
Talking Point Using 'Trumpian' tactics, the former president's inner circle maintained a conspiracy of silence around his cognitive and physical decline
-
Democrats grapple with Biden cover-up fallout ahead of 2028
IN THE SPOTLIGHT Even before his cancer diagnosis, Dems have been grappling with whether the White House's alleged effort to hide Biden's failing health is worth relitigating
-
Biden diagnosed with aggressive prostate cancer
speed read The diagnosis hits close to home, as the former president 'dedicated much of his later career to cancer research'
-
Is Trump trying to take over Congress?
Talking Points Separation of powers at stake in Library of Congress fight
-
The anger fueling the Bernie Sanders and Alexandria Ocasio-Cortez barnstorming tour
Talking Points The duo is drawing big anti-Trump crowds in red states
-
Why the GOP is nervous about Ken Paxton's Senate run
Today's Big Question A MAGA-establishment battle with John Cornyn will be costly
-
Biden slams Trump's Social Security cuts
Speed Read In his first major public address since leaving office, Biden criticized the Trump administration's 'damage' and 'destruction'
-
Bombs or talks: What's next in the US-Iran showdown?
Talking Points US gives Tehran a two-month deadline to deal